Interpreting REACH guidance in the determination of the derived no effect level (DNEL)

Regulatory Toxicology and Pharmacology

Volumn 58, Issue 2, 2010, Pages 323-329

  Kreider, Marisa L ^a   Spencer Williams, E ^b  

^a ChemRisk   (United States)

^b BAYLOR UNIVERSITY   (United States)

Author keywords

DNEL; Occupational exposure limits; REACH; Risk characterization; Styrene

Indexed keywords

ARTICLE; CHEMICAL INDUSTRY; EUROPEAN UNION; GOVERNMENT REGULATION; HUMAN; INDUSTRIAL WORKER; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; OCCUPATIONAL TOXICOLOGY; POPULATION RISK; PRIORITY JOURNAL; RISK ASSESSMENT;

ENVIRONMENTAL MONITORING; EUROPEAN UNION; GUIDELINES AS TOPIC; HAZARDOUS SUBSTANCES; HUMANS; NO-OBSERVED-ADVERSE-EFFECT LEVEL; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH; THRESHOLD LIMIT VALUES;

EID: 77957373535     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2010.07.005     Document Type: Article

References (40)

1. Abraham K., Mielke H., Huisinga W., Gundert-Remy U. Elevated internal exposure of children in simulated acute inhalation of volatile organic compounds: effects of concentration and duration. Arch. Toxicol. 2005, 79:63-73.
2. ACGIH, 2006. Guide to Occupational Exposure Values. American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH.
3. ATSDR, 2007. Toxicological Profile for Styrene. US Department of Health and Human Services, Agency for Toxic Substances and Disease Registry (ATSDR).
4. Chia S.E., Jeyaratnam J., Ong C.N., Ng T.P., Lee H.S. Impairment of color vision among workers exposed to low concentrations of styrene. Am. J. Ind. Med. 1994, 26:481-488.
5. Crump K.S. A new method for determining allowable daily intakes. Fundam. Appl. Toxicol. 1984, 4:854-871.
6. Cruzan G., Cushman J.R., Andrews L.S., Granville G.C., Miller R.R., Hardy C.J., Coombs D.W., Mullins P.A. Subchronic inhalation studies of styrene in CD rats and CD-1 mice. Fundam. Appl. Toxicol. 1997, 35:152-165.
7. Cruzan G., Cushman J.R., Andrews L.S., Granville G.C., Johnson K.A., Bevan C., Hardy C.J., Coombs D.W., Mullins P.A., Brown W.R. Chronic toxicity/oncogenicity study of styrene in CD-1 mice by inhalation exposure for 104 weeks. J. Appl. Toxicol. 2001, 21:185-199.
8. Cruzan G., Bus J., Banton M., Gingell R., Carlson G. Mouse specific lung tumors from CYP2F2-mediated cytotoxic metabolism: an endpoint/toxic response where data from multiple chemicals converge to support a mode of action. Regul. Toxicol. Pharmacol. 2009, 55:205-218.
9. Csanády G.A., Mendrala A.L., Nolan R.J., Filser J.G. A physiologic pharmacokinetic model for styrene and styrene-7,8-oxide in mouse, rat and man. Arch. Toxicol. 1994, 68:143-157.
10. DeCeaurriz J., Desiles J.P., Bonnet P., Marignac B., Muller J., Guenier J.P. Concentration-dependent behavioral changes in mice following short-term inhalation exposure to various industrial solvents. Toxicol. Appl. Pharmacol. 1983, 67:383-389.
11. Deutsche Forschungsgemeinschafr (DFG), 2009. List of MAK and BAT Values. Wiley-VCH, Weinheim.
12. Dills R.L., Ackerlund W.S., Kalman D.A., Morgan M.S. Blood/air partition coefficient determinations: automation and improvement of the equilibrium partitioning in closed systems method. J. Expo. Anal. Environ. Epidemiol. 1993, 3:471-489.
13. EC, Regulation (EC) No. 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorization, and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EC, 93/67/EEC, 93/105/EC and 2001/21/EC. Vol. 1907/2006. European Parliament and the European Commission, 2006.
14. ECB, 2001. Risk Assessment Report for Styrene, vol. 27. Institute for Health and Consumer Protection, European Chemicals Bureau.
15. ECB, 2003. Technical Guidance Document on Risk Assessment. European Chemicals Bureau (ECB).
16. ECHA, 2008. Guidance on Information Requirements and Chemical Safety Assessment Part B: Hazard Assessment. European Chemicals Agency (ECHA).
17. ECHA, 2008. Guidance on Information Requirements and Chemical Safety Assessment, Chapter R.8: Characterisation of Dose [Concentration]-Response for Human Health. European Chemicals Agency (ECHA).
18. ECHA, 2008. Guidance on Information Requirements and Chemical Safety Assessment, Part A: Introduction to the Guidance Document. European Chemicals Agency (ECHA).
19. ECHA, 2009. List of pre-registered substances. <> (accessed 01.07.09). http://apps.echa.europa.eu/preregistered/pre-registered-sub.aspx/.
20. European Chemicals Bureau, 2001. Risk assessment report for styrene. In: Institute for Health and Consumer Protection, (Ed.), vol. 27. European Commission.
21. Fairhurst S. The uncertainty factor in the setting of occupational exposure standards. Ann. Occup. Hyg. 1995, 39:375-385.
22. Gade A.L., Ovrebo S., Hylland K. Testing REACH draft technical guidance notes for conducting chemical safety assessments-the experience of a downstream user of a preparation. Regul. Toxicol. Pharmacol. 2008, 51:168-180.
23. Gargas M.L., Burgess R.J., Voisard D.E., Cason G.H., Andersen M.E. Partition coefficients of low-molecular weight volatile chemicals in various liquids and tissues. Toxicol. Appl. Pharmacol. 1989, 98:87-99.
24. Green T., Lee R., Toqhill A., Meadowcroft S., Lund V., Foster J. The toxicity of styrene to the nasal epithelium of mice and rats: studies on the mode of action and relevance to humans. Chem. Biol. Interact. 2001, 137:185-202.
25. Harvilchuck J.A., Carlson G.P. Effect of multiple doses of styrene and R-styrene oxide on CC10, bax, and bcl-2 expression in isolated Clara cells of CD-1 mice. Toxicology 2009, 259:149-152.
26. Harvilchuck J.A., Pu X., Klaunig J.E., Carlson G.P. Indicators of oxidative stress and apoptosis in mouse whole lung and Clara cells following exposure to styrene and its metabolites. Toxicology 2009, 264:171-178.
27. International Agency for Research on Cancer (IARC), 2002. Monographs on the evaluation of carcinogenic risks to humans, vol. 82. Some Traditional Herbal Medicines, Some Mycotoxins, Naphthalene and Styrene. World Health Organization (WHO).
28. Kishi R., Eguchi T., Yuasa J., Katakura Y., Arata Y., Harabuchi I., Kawai T., Masuchi A. Effects of low-level occupational exposure to styrene on color vision: dose relation with a urinary metabolite. Environ. Res. 2001, 85:25-30.
29. Nielsen G.D., Øvrebø S. Background, approaches and recent trends for setting health-based occupational exposure limits: a minireview. Regul. Toxicol. Pharmacol. 2008, 51:253-269.
30. Odkvist L., Larsby B., Tham R., Hyden D. Vestibulo-oculomotor disturbances caused by industrial solvents. Otolaryngol. Head Neck Surg. 1983, 91:537-539.
31. OEHHA, 2010. OEHHA acute, 8-hour and Chronic Reference Exposure Level (REL) Summary. Office of Environmental Health Hazard Assessment (OEHHA). California Environmental Protection Agency (CalEPA). (accessed 15.06.10. http://www.oehha.ca.gov/air/allrels.html.
32. Rees D.C., Hattis D. Developing quantitative strategies for animal to human extrapolation. Principles and Methods of Toxicology 1994, 275-316. Raven Press, New York. 3rd ed. A.W. Hayes (Ed.).
33. Schenk L., Hansson S.O., Rudén C., Gilek M. Occupational exposure limits: a comparative study. Regul. Toxicol. Pharmacol. 2008, 50:261-270.
34. Seeber A., Blaszkewicz M., Golka K., Hallier E., Kiesswetter E., Schaper M., Thriel C.V. Neurobehavioral effects of experimental exposures to low levels of styrene. Toxicol. Lett. 2004, 151:183-192.
35. Stewart R.D., Dodd H.C., Baretta E.D., Schaffer A.W. Human exposure to styrene vapor. Arch. Environ. Health 1968, 16:656-662.
36. TOXNET, International Toxicity Estimates for Risk (ITER). US national library of medicine. <> (accessed 30.06.2009). http://toxnet.nlm.nih.gov/.
37. Travis K.Z., Pate I., Welsh Z.K. The role of the benchmark dose in a regulatory context. Regul. Toxicol. Pharmacol. 2005, 43:280-291.
38. US EPA, 2002. A Review of the Reference Dose and Reference Concentration Process. US Environmental Protection Agency (US EPA).
39. Williams P.R.D., Paustenbach D.J. Risk characterization. Human and Ecological Risk Assessment: Theory and Practice 2002, 293-366. John Wiley & Sons, Inc., New York. D.J. Paustenbach (Ed.).
40. Williams E.S., Panko J.M., Paustenbach D.J. The European Union's REACH regulation: a review of its history and requirements. Crit. Rev. Toxicol. 2009, 39:553-575.